North America Synthetic Biology Market Size to Hit USD 9.25 Billion by 2026

North America Synthetic Biology Market (By Product: Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism; By Technology: NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies; By Application: Healthcare, Clinical, Non-healthcare; By End Use: Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 582  |  Published : 08 May 2026   |  Delivery : Immediate   |  Format : Excel   |  Author : Aditi Shivarkar, Aman Singh
Revenue,
USD 7.97 Bn
Forecast Year,
USD 35.16 Bn
CAGR, 2026 - 2035
16%
Report Coverage
North America
Download Databook

The North America synthetic biology market size was estimated at USD 7.97 billion in 2025 and is predicted to reach around USD 35.16 billion by 2035, expanding at a CAGR of 16% from 2026 to 2035. The market is expected to grow due to higher investments in R&D, advancements in technology such as AI and ML in biotech, along with applications in medicine, agriculture, and sustainability.

North America Synthetic Biology Market Statical Scope

Reports Attributes Statistics
Market Size in 2025 USD 7.97 Billion
Market Size in 2026 USD 9.25 Billion
Market Size by 2035 USD 35.16 Billion
CAGR 2026 to 2035 16%
Base Year 2025
Forecast Period 2026 to 2035

The North America synthetic biology market also propels due to advancements in domains such as genome editing and NGS technologies. Higher demand for personalized medicine and gene therapy approval creates a huge market demand in the healthcare industry. Industrial applications and agricultural biotech also have a vital share in the growth of the market.

North America Synthetic Biology Market, By Product Outlook 2025 (%)

Segments Shares (%)
Oligonucleotide/Oligo Pools and Synthetic DNA 32%
Enzymes 18%
Cloning Technologies Kits 14%
Xeno-Nucleic Acids 8%
Chassis Organism 28%
  • Oligonucleotide/Oligo Pools and Synthetic DNA - The segment holds 32% of the market share and is driven by its major role in gene synthesis, sequencing, and synthetic biology research applications.
  • Enzymes - The segment accounts for 18% of the market share due to its fundamental role in DNA manipulation, amplification, and biochemical reactions.

North America Synthetic Biology Market, By Technology Outlook 2025 (%)

Segments Shares (%)
NGS Technology 24%
PCR Technology 20%
Genome Editing Technology 26%
Bioprocessing Technology 18%
Other Technologies 12%
  • NGS Technology - The segment accounts for 24% of the market share and is supported by growing demand for high-throughput sequencing and genome analysis.
  • PCR Technology - The segment has a notable share of 20% of the market and is driven by its widespread use in DNA amplification and diagnostic applications.
  • Genome Editing Technology - The segment holds a massive 26% share of the market and is majorly driven by increasing adoption of advanced tools like CRISPR for precise genetic modifications.

North America Synthetic Biology Market, By Application Outlook 2025 (%)

Segments Shares (%)
Healthcare 40%
Non-Healthcare 60%
  • Healthcare - The segment has a notable share of 40% of the market in 2025 and is propelled by increasing use in drug development, gene therapy, and personalized medicine.
  • Non-Healthcare - The segment has a dominant share of 60% and is driven by its higher demand in industrial biotechnology , agriculture, and environmental solutions.

North America Synthetic Biology Market, By End Use Outlook 2025 (%)

Segments Shares (%)
Biotechnology/Pharmaceutical Companies 48%
Academic and Research Institutes 32%
Others (including dental clinics, etc) 20%
  • Biotechnology/Pharmaceutical Companies - The segment accounts for 48% of the market share and is driven by extensive R&D investments along with the adoption of synthetic biology in drug discovery and development.
  • Academic and Research Institutes - The segment holds 32% of the market share and is driven by ongoing research, innovation, and government funding.

Top Companies in the North America Synthetic Biology Market

  • Bota Biosciences Inc.
  • Codexis, Inc.
  • Creative Biogene.
  • Creative Enzymes.
  • Enbiotix, Inc.
  • Illumina, Inc.
  • Merck Kgaa (Sigma-Aldrich Co. Llc)
  • New England Biolabs
  • Eurofins Scientific
  • Novozymes
  • Pareto Bio, Inc.
  • Scarab Genomics, Llc
  • Synthego
  • Synthetic Genomics Inc.
  • Thermo Fisher Scientific, Inc.

Segments Covered in the Report

By Product

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism

By Technology

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Other Technologies

By Application

  • Healthcare
    • Clinical
      • Bio/Pharmaceuticals
      • Diagnostics
    • Non-Clinical
  • Non-healthcare
    • Biotech Crops
    • Specialty Chemicals
    • Bio-fuels
    • Others

By End Use

  • Biotechnology and Pharmaceutical companies
  • Academic and Research Institutes
  • Others

List of Tables & Figures

List of Tables

  • Table 1: North America Synthetic Biology Market Size, by Product, 2025-2035 (USD Billion)
  • Table 2: North America Synthetic Biology Market Size, by Technology, 2025-2035 (USD Billion)
  • Table 3: North America Synthetic Biology Market Size, by Application, 2025-2035 (USD Billion)
  • Table 4: North America Synthetic Biology Market Size, by End Use, 2025-2035 (USD Billion)
  • Table 5: North America Synthetic Biology Market Size, by Oligonucleotide/Oligo Pools and Synthetic DNA, 2025-2035 (USD Billion)
  • Table 6: North America Synthetic Biology Market Size, by Enzymes, 2025-2035 (USD Billion)
  • Table 7: North America Synthetic Biology Market Size, by Cloning Technologies Kits, 2025-2035 (USD Billion)
  • Table 8: North America Synthetic Biology Market Size, by Xeno-Nucleic Acids, 2025-2035 (USD Billion)
  • Table 9: North America Synthetic Biology Market Size, by Chassis Organism, 2025-2035 (USD Billion)
  • Table 10: North America Synthetic Biology Market Size, by NGS Technology, 2025-2035 (USD Billion)
  • Table 11: North America Synthetic Biology Market Size, by PCR Technology, 2025-2035 (USD Billion)
  • Table 12: North America Synthetic Biology Market Size, by Genome Editing Technology, 2025-2035 (USD Billion)
  • Table 13: North America Synthetic Biology Market Size, by Bioprocessing Technology, 2025-2035 (USD Billion)
  • Table 14: North America Synthetic Biology Market Size, by Other Technologies, 2025-2035 (USD Billion)
  • Table 15: North America Synthetic Biology Market Size, by Healthcare Application, 2025-2035 (USD Billion)
  • Table 16: North America Synthetic Biology Market Size, by Clinical Application, 2025-2035 (USD Billion)
  • Table 17: North America Synthetic Biology Market Size, by Non-healthcare Application, 2025-2035 (USD Billion)
  • Table 18: North America Synthetic Biology Market Size, by Biotechnology and Pharmaceutical Companies, 2025-2035 (USD Billion)
  • Table 19: North America Synthetic Biology Market Size, by Academic and Research Institutes, 2025-2035 (USD Billion)
  • Table 20: North America Synthetic Biology Market Size, by Others End Use, 2025-2035 (USD Billion)
  • Table 21: U.S. Synthetic Biology Market Size, 2025-2035 (USD Billion)
  • Table 22: Canada Synthetic Biology Market Size, 2025-2035 (USD Billion)
  • Table 23: Mexico Synthetic Biology Market Size, 2025-2035 (USD Billion)

List of Figures

  • Figure 1: North America Synthetic Biology Market Share, by Product, 2025 (%)
  • Figure 2: North America Synthetic Biology Market Share, by Technology, 2025 (%)
  • Figure 3: North America Synthetic Biology Market Share, by Application, 2025 (%)
  • Figure 4: North America Synthetic Biology Market Share, by End Use, 2025 (%)
  • Figure 5: North America Synthetic Biology Market Forecast, 2025-2035 (USD Billion)
  • Figure 6: Oligonucleotide/Oligo Pools & Synthetic DNA Market Forecast, 2025-2035 (USD Billion)
  • Figure 7: Enzymes Segment Market Forecast, 2025-2035 (USD Billion)
  • Figure 8: Cloning Technologies Kits Market Forecast, 2025-2035 (USD Billion)
  • Figure 9: Xeno-Nucleic Acids Market Forecast, 2025-2035 (USD Billion)
  • Figure 10: Chassis Organism Market Forecast, 2025-2035 (USD Billion)
  • Figure 11: NGS Technology Market Forecast, 2025-2035 (USD Billion)
  • Figure 12: PCR Technology Market Forecast, 2025-2035 (USD Billion)
  • Figure 13: Genome Editing Technology Market Forecast, 2025-2035 (USD Billion)
  • Figure 14: Bioprocessing Technology Market Forecast, 2025-2035 (USD Billion)
  • Figure 15: Healthcare Application Market Forecast, 2025-2035 (USD Billion)
  • Figure 16: Clinical Application Market Forecast, 2025-2035 (USD Billion)
  • Figure 17: Non-healthcare Application Market Forecast, 2025-2035 (USD Billion)
  • Figure 18: End Use Segment Comparison, 2025-2035 (USD Billion)
  • Figure 19: Country-wise Market Share, North America, 2025 (%)

 

Research Methodology